Cargando…
Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites
CRISPR/Cas9-based genome editing has revolutionized experimental molecular biology and entered the clinical world for targeted gene therapy. Identifying DNA modifications occurring at CRISPR/Cas9 target sites is critical to determine efficiency and safety of editing tools. Here we show that insertio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237045/ https://www.ncbi.nlm.nih.gov/pubmed/35760782 http://dx.doi.org/10.1038/s41467-022-31322-3 |
_version_ | 1784736679591936000 |
---|---|
author | Tao, Jianli Wang, Qi Mendez-Dorantes, Carlos Burns, Kathleen H. Chiarle, Roberto |
author_facet | Tao, Jianli Wang, Qi Mendez-Dorantes, Carlos Burns, Kathleen H. Chiarle, Roberto |
author_sort | Tao, Jianli |
collection | PubMed |
description | CRISPR/Cas9-based genome editing has revolutionized experimental molecular biology and entered the clinical world for targeted gene therapy. Identifying DNA modifications occurring at CRISPR/Cas9 target sites is critical to determine efficiency and safety of editing tools. Here we show that insertions of LINE-1 (L1) retrotransposons can occur frequently at CRISPR/Cas9 editing sites. Together with PolyA-seq and an improved amplicon sequencing, we characterize more than 2500 de novo L1 insertions at multiple CRISPR/Cas9 editing sites in HEK293T, HeLa and U2OS cells. These L1 retrotransposition events exploit CRISPR/Cas9-induced DSB formation and require L1 RT activity. Importantly, de novo L1 insertions are rare during genome editing by prime editors (PE), cytidine or adenine base editors (CBE or ABE), consistent with their reduced DSB formation. These data demonstrate that insertions of retrotransposons might be a potential outcome of CRISPR/Cas9 genome editing and provide further evidence on the safety of different CRISPR-based editing tools. |
format | Online Article Text |
id | pubmed-9237045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-92370452022-06-29 Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites Tao, Jianli Wang, Qi Mendez-Dorantes, Carlos Burns, Kathleen H. Chiarle, Roberto Nat Commun Article CRISPR/Cas9-based genome editing has revolutionized experimental molecular biology and entered the clinical world for targeted gene therapy. Identifying DNA modifications occurring at CRISPR/Cas9 target sites is critical to determine efficiency and safety of editing tools. Here we show that insertions of LINE-1 (L1) retrotransposons can occur frequently at CRISPR/Cas9 editing sites. Together with PolyA-seq and an improved amplicon sequencing, we characterize more than 2500 de novo L1 insertions at multiple CRISPR/Cas9 editing sites in HEK293T, HeLa and U2OS cells. These L1 retrotransposition events exploit CRISPR/Cas9-induced DSB formation and require L1 RT activity. Importantly, de novo L1 insertions are rare during genome editing by prime editors (PE), cytidine or adenine base editors (CBE or ABE), consistent with their reduced DSB formation. These data demonstrate that insertions of retrotransposons might be a potential outcome of CRISPR/Cas9 genome editing and provide further evidence on the safety of different CRISPR-based editing tools. Nature Publishing Group UK 2022-06-27 /pmc/articles/PMC9237045/ /pubmed/35760782 http://dx.doi.org/10.1038/s41467-022-31322-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Tao, Jianli Wang, Qi Mendez-Dorantes, Carlos Burns, Kathleen H. Chiarle, Roberto Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites |
title | Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites |
title_full | Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites |
title_fullStr | Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites |
title_full_unstemmed | Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites |
title_short | Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites |
title_sort | frequency and mechanisms of line-1 retrotransposon insertions at crispr/cas9 sites |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237045/ https://www.ncbi.nlm.nih.gov/pubmed/35760782 http://dx.doi.org/10.1038/s41467-022-31322-3 |
work_keys_str_mv | AT taojianli frequencyandmechanismsofline1retrotransposoninsertionsatcrisprcas9sites AT wangqi frequencyandmechanismsofline1retrotransposoninsertionsatcrisprcas9sites AT mendezdorantescarlos frequencyandmechanismsofline1retrotransposoninsertionsatcrisprcas9sites AT burnskathleenh frequencyandmechanismsofline1retrotransposoninsertionsatcrisprcas9sites AT chiarleroberto frequencyandmechanismsofline1retrotransposoninsertionsatcrisprcas9sites |